Rytmonorm 150mg 30 Tablets

Rytmonorm 150 mg (30 Tablets)

Active Ingredient:

• Propafenone Hydrochloride 150 mg

Therapeutic Class:
Class IC Antiarrhythmic Agent

Indications:

• Treatment and prevention of certain types of serious cardiac arrhythmias, including:

  • Paroxysmal supraventricular tachycardia (PSVT)

  • Atrial fibrillation or atrial flutter (to maintain normal sinus rhythm)

  • Ventricular arrhythmias (ventricular tachycardia or premature ventricular contractions)

Dosage:

• The usual adult starting dose is 150 mg every 8 hours (three times daily).

• Dose may be increased gradually up to 300 mg every 8 hours depending on response and tolerance.

• Tablets should be swallowed whole with water, with or without food, at evenly spaced intervals.

• Dosage adjustment may be needed for elderly patients or those with liver or kidney impairment.

Precautions:

• Contraindicated in patients with:

  • Significant structural heart disease or severe heart failure

  • Cardiogenic shock

  • Marked bradycardia or severe conduction disorders

  • Known hypersensitivity to propafenone

• Use with caution in patients with liver or kidney dysfunction, electrolyte imbalance, or asthma (due to mild beta-blocking effect).

• Monitor ECG regularly to detect QRS or QT prolongation.

• Avoid use with other antiarrhythmic drugs unless strictly supervised.

Possible Side Effects:

• Dizziness, fatigue, or headache

• Nausea, vomiting, metallic taste, or constipation

• Palpitations, chest pain, or shortness of breath

• Visual disturbances (blurred vision, double vision)

• Rare: worsening arrhythmia (proarrhythmic effect), hypotension, or heart block

Drug Interactions:

• May interact with beta-blockers, digoxin, warfarin, or other antiarrhythmics.

• Avoid alcohol and limit caffeine as they may increase side effects.

Storage:
Store below 25°C, in a dry place, away from light and moisture. Keep out of reach of children.